Natural polysaccharide-incorporated hydroxyapatite as size-changeable, nuclear-targeted nanocarrier for efficient cancer therapy

Nuclear-targeted, size-changeable polysaccharide hybrid hydroxyapatite nanoparticles were prepared for the delivery of doxorubicin for cancer therapy, showing low toxicity to healthy tissue cells but strong killing effect on tumor cells.